ALB and coronary artery disorder: In contrast, our study introduces a novel perspective by prospectively validating the Neutrophil-to-Albumin Ratio (NPAR)—a simple, cost-effective, and integrative inflammatory-nutritional biomarker—in a large, broadly representative CHD cohort with long-term follow-up.